Biospectator Interview : Minsoo Choi, CEO of NetTargets

NetTargets introduced the core platforms N-MAP and N-CAP at the Biopharma Tech concert on May 21st.

For more detailed information please refer to this Korean news article.

AI Times recognized NetTargets as one of the notable AI startups in biopharmaceuticals in 2021.

05 Jan 2021

We are pleased to be one of top 10 biotech startsups in APAC 2020 selected by Startupcity magazine.

30 Dec 2020

In this 7th Bluepoint demo day, NetTargets explained how we are solving problems from traditional industries with our technologies.

24 Nov 2020

Our next news and events are coming soon